Pharmacological management of co-morbid conditions at the end of life: is less more?
Tóm tắt
Từ khóa
Tài liệu tham khảo
Coebergh JWW, Janssen-Heijnen MLG, Post PN et al (1999) Serious co-morbidity among unselected cancer patients newly diagnosed in the southeastern part of the Netherlands in 1993–1996. J Clin Epidemiology 52(12):1131–1136
Ryan C, O’Mahony D, Kennedy J et al (2009) Potentially inappropriate prescribing in an Irish elderly population in primary care. B J Clin Pharmacol 68(6):936–947
Walsh EK, Cussen K (2010) “Take ten minutes”: a dedicated ten minute medication review reduces polypharmacy in the elderly. Ir Med J 103(8):236–238
Amarenco P, Labreuche J, Lavallee P (2004) Statins in stroke prevention and carotid atheroscelerosis: systematic review and up-to-date meta-analysis. Stroke 35:2902–2909
Uretsky BF, Young JB, Shahidi FE et al (1993) Randomised study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED trial. PROVED investigation group. J Am Coll Cardiol 22(4):955–962
Stevenson J, Miller C, Abernethy AP et al (2004) Managing comorbidities in patients at the end of life. BMJ 329:909–912
Silveira MJ, Segnini Kazanis A, Shevrin MP et al (2008) Statins in the last six months of life: a recognizable life-limiting condition does not decrease their use. J Pall Med 11(5):685–693
Sheehy-Skeffington B, McLean S, Bramwell M, O’Leary N, O’Gorman A (in press) Caregivers experiences of managing medications of palliative care patients at the end of life—a qualitative study
Garfinkel D, Mangin D (2010) Feasibility study of a systematic approach for discontinuation of multiple medications in older adults. Arch Intern Med 170(18):1648–1654
Heeschen C, Hamm CW, Laufs U et al (2002) Withdrawal of statins increases event rates in patients with acute coronary syndromes. Circulation 105:1446–1452
McGowan MP, for the Treating to New Target Study Group (2004) There is no evidence for an increase in acute coronary syndromes after short-term abrupt discontinuation of statins in stable cardiac patients. Circulation 110:2333–2335
Holmes HM, Cox-Hayley JT, Alexander GC et al (2006) Reconsidering medication appropriateness for patients late in life. Arch Intern Med 166:605–609
Currow D, Stevenson J, Abernethy A et al (2007) Prescribing in palliative care as death approaches. J Am Geriatr Soc 55:590–595
Hanlon JT, Schmader KE, Samsa GP et al (1992) A method for assessing drug therapy appropriateness. J Clin Epidemiol 45:1045–1051
